Cita APA (7a ed.)
Knoll, R. L., Brauny, M. M., Robert, E., Cloos, L., Waser, L., Hilbert, K., . . . Forslund-Startceva, S. K. (2025). CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: The IMMProveCF phase IV trial. Nature Communications. https://doi.org/10.1038/s41467-025-64218-z
Cita Chicago Style (17a ed.)
Knoll, Rebecca Luise, et al. "CFTR Modulator Therapy Drives Microbiome Restructuring Through Improved Host Physiology in Cystic Fibrosis: The IMMProveCF Phase IV Trial." Nature Communications 2025. https://doi.org/10.1038/s41467-025-64218-z.
Cita MLA (9a ed.)
Knoll, Rebecca Luise, et al. "CFTR Modulator Therapy Drives Microbiome Restructuring Through Improved Host Physiology in Cystic Fibrosis: The IMMProveCF Phase IV Trial." Nature Communications, 2025, https://doi.org/10.1038/s41467-025-64218-z.
Precaución: Estas citas no son 100% exactas.